$RXRX RECURSION PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in RECURSION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in RECURSION PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in RECURSION PHARMACEUTICALS, INC. for free.
CIK Number: 0001601830
IRS Number: 464099738
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: RXRX
Company Address: 41S RIO GRANDE STREET SALT LAKE CITY 84101
Phone number: (385) 269-0203
Former name: Recursion Pharmaceuticals, LLC, date of change: 2014-03-05
RECURSION PHARMACEUTICALS, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Virani Shafique | Chief Corp. Dev. Of ... | Option Exercise | C | 2.22 | 732,000 | 1,625,040 | 732,000 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Virani Shafique | Chief Corp. Dev. Of ... | Option Exercise | C | 2.22 | 732,000 | 1,625,040 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Virani Shafique | Chief Corp. Dev. Of ... | Buy | J | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Virani Shafique | Chief Corp. Dev. Of ... | Sell | J | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Option Exercise | C | 2.22 | 1,500,000 | 3,330,000 | 1,500,000 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Option Exercise | C | 2.22 | 820,313 | 1,821,095 | 820,313 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Option Exercise | C | 2.22 | 1,500,000 | 3,330,000 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Option Exercise | C | 2.22 | 820,313 | 1,821,095 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Option Exercise | C | 0.00 | 149,077 | 0 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Buy | J | 0.00 | 528,762 | 0 | 528,762 | 0 to 528.8 K |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Sell | J | 0.00 | 528,762 | 0 | 0 | 528.8 K to 0 (-100.00 %) |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Secora Michael | Chief Financial Off ... | Buy | C | 0.00 | 149,077 | 0 | 528,762 | 379.7 K to 528.8 K (+39.26 %) |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 0.00 | 32,685 | 0 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 0.00 | 22,698 | 0 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 18.00 | 27,778 | 500,004 | 27,778 |
View all RECURSION PHARMACEUTICALS, INC. insider transactions.